A REVIEW ARTICLE ON COVID-19 PANDEMIC AND CARDIOVASCULAR DISEASE
Sarvesh Manoj Jadhav*, Hrishikesh Tryambak Kadam, Prashant Subhash Gaikwad, Tushar Lokhande
ABSTRACT
There seems to be a unique interplay between 2019 novel coronavirus
(SARS-CoV-2) and cardiovascular diseases, although it is
predominantly a respiratory illness. Patients with pre-existing
cardiovascular co-morbidities appear to be at highest risk for mortality
from coronavirus disease 2019 (COVID-19) along with the elderly;
COVID-19 also contributes to cardiovascular complications, including
acute coronary syndromes, arrhythmias, myocarditis, acute heart failure,
and, in the most severe cases, cardiogenic shock and death. Several
medications proposed in the treatment of COVID-19 require cardiac
monitoring owing to their cardiac-specific adverse effects. Ultimately,
the COVID-19 pandemic has jeopardized the safety of heart transplantation and has placed
transplant recipients on immunosuppressive therapies at significant risk. In this article, the
authors summarize the rapidly emerging data on the cardiovascular implications of SARSCoV-
2 and COVID-19.
Keywords: SARS-CoV-2, coronavirus, COVID-19, pandemic, cardiovascular diseases, myocarditis, heart transplantation.
[Full Text Article]